Shopping Cart 0
Cart Subtotal

Global 1,4,7,10-Tetraazacyclododecane (Cyclen) Market Outlook 2017-2022

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 3000

Access to Printed Report; No Soft Copy
Print Option: N/A
Copy Option: N/A
Deliverable Format : Printed Publication/ Book by Post

Hard Copy License
USD 3100

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 5000
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase


Cyclen or 1,4,7,10-tetraazacyclododecane is a macrocycle and the aza analogue of the crown ether 12-crown-4. Derivatives of cyclen are larger cyclic polyamines but the repeating unit (ethyleneimine, -CH2CH2NH-) is always the same. Like crown ethers, cyclen compounds are capable of selectively binding cations. They are used as a ligand in chemistry for instance with chemicals used in MRI contrast agents.

The report covers forecast and analysis for the cyclen market on a global and regional level. The study provides historic data of 2012-2016 along with a forecast from 2017 to 2022 based on both volumes and revenue. The study includes drivers and restraints for the cyclen market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the cyclen market on a global level.

The report has been prepared based on the synthesis, analysis, and interpretation of information about the global cyclen market collected from specialized sources. The competitive landscape section of the report provides a clear insight into the market share analysis of key industry players. Company overview, financial overview, product portfolio, new project launched, recent development analysis are the parameters included in the profile.

The study provides a decisive view on the cyclen market by segmenting the market based on applications. All the application segments have been analyzed based on present and future trends and the market is estimated from 2017 to 2022.

Key Applications

MRI Contrast Agents

- ProHance

- Gadavist

- Dotarem


Key Regions

North America


Asia Pacific

Key Vendors


Bayer Vital



Hubei Tianshu

Heryi Pharma

Taicang Qianjing

Chem Stone


Xiamen Huasing

Key Questions Answered in this Report

What will the market size be in 2022?

What are the key factors driving the global cyclen market?

What are the challenges to market growth?

Who are the key players in the cyclen market?

What are the market opportunities and threats faced by the key players?


Table Of Content


Part 1. Exclusive Summary

Part 2. Methodology

2.1 Research Methodology

2.2 Geographic Scope

2.3 Years Considered

Part 3. Introduction

3.1 Product Overview

3.2 Applications of Cyclen

3.3 Manufacturing Process

3.4 Raw Materials

3.5 Cost Analysis

Part 4. Competitive Landscape

4.1 Global Cyclen Market, by Volume 2012-2017

4.1.1 Overview

4.1.2 Global Cyclen Market, by Volume, by Company

4.1.3 Top 3 Companies by Volume Share

4.2 Global Cyclen Market, by Revenue 2012-2017

4.2.1 Overview

4.2.2 Global Cyclen Market, by Revenue, by Company

4.2.3 Top 3 Companies by Revenue Share

Part 5. Market Dynamics

5.1 Market Drivers

5.2 Challenges

5.3 Market Trends

Part 6. Segmentation by Application

6.1 Overview

6.2 ProHance Market

6.3 Gadavist Market

6.4 Dotarem Market

Part 7. North America

7.1 North American Cyclen Market Size

7.2 by Country

7.2.1 United States

7.2.2 Canada

Part 8. Europe

8.1 European Cyclen Market Size

8.2 by Country

8.2.1 Germany

8.2.2 UK

8.2.3 France

Part 9. Asia-Pacific

9.1 Asia-Pacific Cyclen Market Size

9.2 by Country

9.2.1 China

9.2.2 Japan

9.2.3 India

Part 10. Cyclen Market Forecast

10.1 Global Cyclen Market Size 2017-2022

10.2 Global Cyclen Market by Region 2017-2022

10.2.1 North America

10.2.2 Europe

10.2.3 Asia-Pacific

10.4 Global Cyclen Market by Application 2017-2022

Part 11. Company Profiles

11.1 Guerbet

11.1.1 Business Overview

11.1.2 Products Offered

11.1.3 Financials

11.2 Bayer Vital

11.3 Bracco

11.4 Bolon

11.5 Hubei Tianshu

11.6 Heryi Pharma

11.7 Taicang Qianjing

11.8 Chem Stone

11.9 Nanhua

11.10 Xiamen Huasing


Part 12. Appendix

12.1 Abbreviations

12.2 Disclaimer

Licence Rights

Single License

allows one individual to access the purchased report

Site License

allows five individuals to access the purchased report

Enterprise License

allows all employees of an organization to access the purchased report

Section Purchase

To know more information on Purchase by Section, please send a mail to